Short Interest in Viemed Healthcare, Inc. (NASDAQ:VMD) Drops By 19.4%

Viemed Healthcare, Inc. (NASDAQ:VMD) saw a large decrease in short interest during the month of November. As of November 15th, there was short interest totalling 291,200 shares, a decrease of 19.4% from the October 31st total of 361,200 shares. Based on an average daily trading volume, of 166,700 shares, the days-to-cover ratio is currently 1.7 days. Approximately 0.9% of the company’s stock are short sold.

Viemed Healthcare Stock Performance

Viemed Healthcare stock opened at $8.67 on Friday. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.31 and a quick ratio of 1.19. Viemed Healthcare has a 12 month low of $6.21 and a 12 month high of $10.44. The company has a fifty day moving average price of $8.61 and a two-hundred day moving average price of $7.61. The company has a market cap of $337.61 million, a PE ratio of 32.11 and a beta of 1.43.

Viemed Healthcare (NASDAQ:VMD) last announced its quarterly earnings data on Wednesday, November 6th. The company reported $0.10 earnings per share for the quarter, beating analysts’ consensus estimates of $0.08 by $0.02. Viemed Healthcare had a net margin of 4.87% and a return on equity of 8.72%. The business had revenue of $58.00 million during the quarter.

Insider Activity

In other news, Director Nitin Kaushal sold 30,000 shares of the stock in a transaction dated Monday, November 11th. The shares were sold at an average price of $9.56, for a total transaction of $286,800.00. Following the transaction, the director now owns 126,843 shares of the company’s stock, valued at approximately $1,212,619.08. This trade represents a 19.13 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Randy E. Dobbs sold 36,261 shares of the business’s stock in a transaction dated Wednesday, November 13th. The shares were sold at an average price of $9.28, for a total value of $336,502.08. Following the completion of the sale, the director now directly owns 107,706 shares of the company’s stock, valued at approximately $999,511.68. This represents a 25.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 72,256 shares of company stock worth $674,739. 20.00% of the stock is currently owned by insiders.

Institutional Trading of Viemed Healthcare

Several hedge funds have recently made changes to their positions in the stock. National Bank of Canada FI grew its stake in Viemed Healthcare by 91.2% during the 3rd quarter. National Bank of Canada FI now owns 3,346 shares of the company’s stock worth $25,000 after buying an additional 1,596 shares during the last quarter. Oppenheimer Asset Management Inc. grew its position in shares of Viemed Healthcare by 5.6% during the third quarter. Oppenheimer Asset Management Inc. now owns 30,222 shares of the company’s stock worth $222,000 after acquiring an additional 1,601 shares during the last quarter. The Manufacturers Life Insurance Company increased its holdings in shares of Viemed Healthcare by 14.7% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 14,918 shares of the company’s stock worth $98,000 after acquiring an additional 1,912 shares during the period. Victory Capital Management Inc. lifted its position in Viemed Healthcare by 21.1% in the 2nd quarter. Victory Capital Management Inc. now owns 12,791 shares of the company’s stock valued at $84,000 after purchasing an additional 2,226 shares during the last quarter. Finally, Panagora Asset Management Inc. boosted its stake in Viemed Healthcare by 1.1% during the 2nd quarter. Panagora Asset Management Inc. now owns 272,383 shares of the company’s stock valued at $1,784,000 after purchasing an additional 2,904 shares during the period. Institutional investors own 74.24% of the company’s stock.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.